FDA COLLECTING VOLUNTARY INDUSTRY COMPLIANCE DATA
This article was originally published in The Tan Sheet
Executive Summary
FDA COLLECTING VOLUNTARY INDUSTRY COMPLIANCE DATA that will be used as another measure of the agency's enforcement activities along with approval, disapproval and enforcement information, Office of Enforcement Director Daniel Michels told the Food & Drug Law Institute annual meeting Dec. 14. "We think it is one of the best measures of success on both sides," Michels said. In the future, "we can collectively take pride in the reality that a violative situation was corrected without having to go to a formal enforcement action."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning